Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1Areceptors
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The purpose of the present study was to examine, by in vivo microdialysis technique, the effects of triple acting monoamine reuptake inhibitors, constructed by combinations of a selective serotonin reuptake inhibitor citalopram with a noradrenaline/dopamine reuptake inhibitor methylphenidate and a serotonin/noradrenaline reuptake inhibitor venlafaxine with a dopamine reuptake inhibitor GBR12909, on extracellular levels of serotonin (5-HT), noradrenaline (NA) and dopamine (DA) in the prefrontal cortex (PFC) of anaesthetized rats. At the highest dose tested, adjunctive methylphenidate (10 mg/kg s.c.) to citalopram markedly attenuated by 63% the extracellular levels of 5-HT as compared to the levels induced by citalopram (5 mg/kg i.p.) alone, whereas the overall DA concentrations significantly increased to about 149% of those induced by methylphenidate alone. Similarly, the combination of venlafaxine with GBR12909 (10 mg/kg s.c.) caused a reduction of 5-HT levels to 66% of the levels induced by venlafaxine (10 mg/kg i.p.) alone, whereas the overall DA levels increased to 151% of the venlafaxine-treated group. The extracellular levels of NA were only marginally affected by the treatments with combined reuptake inhibitors compared to the effects induced by methylphenidate or venlafaxine alone. The modulatory effects of combined administration of the DA/NA reuptake inhibitors with the 5-HT reuptake inhibitors (citalopram and venlafaxine) on potentiation of DA and attenuation of 5-HT efflux were completely reversed by a pre-treatment with the 5-HT 1A receptor antagonist WAY-100635. These findings suggest a crucial role played by the 5-HT 1A receptors in balancing the reuptake inhibitory efficacy for the enhancement of 5-HT and DA transmission in the PFC by the drugs combining the reuptake inhibition of all three monoamines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Celada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09917.2001 · Cited by 497 · cited 2×
“It seems well established that 5-HT control the PFC activity by mediating a balance between the excitatory 5-HT2A receptors and the inhibitory 5-HT1A receptors both located at the PFC pyramidal cells and the local GABA interneurons (Martin-Ruiz et al., 2001; Celada et al., 2001; Puig et al., 2003; Santana et al., 2004…”
BackgroundPharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492 · cited 1×
“In contrast, citalopram increased the extracellular 5-HT levels in the PFC without any significant influence on DA or NA values, a result also in close agreement with other reports (Hyttel, 1994; Millan et al., 1999; Bymaster and Felder, 2002).”
ResultSantana, N. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh070 · Cited by 486 · cited 1×
“…the PFC activity by mediating a balance between the excitatory 5-HT2A receptors and the inhibitory 5-HT1A receptors both located at the PFC pyramidal cells and the local GABA interneurons (Martin-Ruiz et al., 2001; Celada et al., 2001; Puig et al., 2003; Santana et al., 2004; Adell et al., 2005).”
BackgroundAmargos-Bosch, M. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhg128 · Cited by 370 · cited 5×
“…SERT, DAT and NET inhibitors suggest that the 5-HT1A receptors, rather than the 5-HT2A receptors play a central role in mediating the effects of triple-acting monoamine reuptake inhibitors on DA and 5-HT efflux in the prefrontal cortical areas (Amargós-Bosch et al., 2004; Diaz-Mataix et al., 2005).”
BackgroundInfluentialJankowski, M. P., & Sesack, S. R. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.10976 · Cited by 186
Kihara, T., & Ikeda, M. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24303-8 · Cited by 123 · cited 2×
“, 2006) The present findings on the effects of venlafaxine on the monoamines are in close agreement with the previous reports (Engleman et al., 1995; Kihara and Ikeda, 1995; Millan et al., 2001), although some microdialysis studies failed to show the effect of venlafaxine on 5-HT levels (Dawson et al.”
ResultMiner, L. H., Jedema, H. P., Moore, F. W., Blakely, R. D., Grace, A. A., & Sesack, S. R. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4450-05.2006 · Cited by 107
Weikop, P., Kehr, J., & Scheel-Krüger, J. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800311 · Cited by 57 · cited 2×
“…at a dose of 5 mg/kg on extracellular levels of 5-HT in the PFC. Similarly, the dose of venlafaxine was selected in agreement with the previous study (Weikop et al., 2004) showing the dose related effects on all three monoamines and the maximal effect on the 5-HT levels at the dose of 10 mg/kg.”
BackgroundMethodSelf-citation
Cited by
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
“…a NRI omponent or a DA reuptake inhibitor further increases 5HT levls in hippocampus but restricts 5HT levels in the PFC, probably ecause NA uptake inhibition also potentiates DA in PFC but not lsewhere (Weikop et al., 2007a,b), which might explain the greater fficacy of SNRIs such as venlafaxine.”
BackgroundSelf-citationPotentiating glymphatic drainage minimizes post-traumatic cerebral oedema
Hussain, R., Tithof, J., Wang, W., Cheetham-West, A., Song, W., Peng, W., Sigurdsson, B., Kim, D., Sun, Q., Peng, S., et al. (2023) · Nature · doi:10.1038/s41586-023-06737-7 · Cited by 169
Self-citationAndrews, P. W., Kornstein, S. G., Halberstadt, L. J., Gardner, C. O., & Neale, M. C. (2011) · Frontiers in Psychology · doi:10.3389/fpsyg.2011.00159 · Cited by 107
“…SNRI Kihara and Ikeda (1995), Koch et al. (2003) Milnacipran 94 147 119 SNRI Marien et al. (2007) Venlafaxine 250 230 167 SNRI Koch et al. (2003), Weikop et al. (2007) Citalopram 466 90 71 SSRI Bymaster et al. (2002) Escitalopram 466 90 71 SSRI See text Fluoxetine 368 189 150 SSRI Bymaster et…”
MethodWitkin, J. M., Monn, J. A., Schoepp, D. D., Li, X., Overshiner, C., Mitchell, S. N., Carter, G., Johnson, B., Rasmussen, K., & Rorick-Kehn, L. M. (2016) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.233627 · Cited by 105
“In contrast, citalopramdid not increase levels of dopamine in the nucleus accumbens at doses known to elevate extracellular serotonin levels in other areas (5 mg/kg, i.p.) (Weikop et al., 2007).”
Background
Metadata
- Authors
- Weikop, P., Kehr, J., & Scheel-Krüger, J.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2007-11
- Volume
- 21
- Issue
- 8
- Pages
- 795-804
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2082791101
- Cited by
- 37
- References
- 8
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.